Received May 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUCELVAX) | SEQIRUS, INC. | UNK | 946615 | — |
Ingredients of vaccine following possible allergic reaction; This spontaneous case, initially received on 22-Apr-2025, was reported by a non health professional and concerns a female patient. Administration of company suspect drug: On an unknown date, the patient received Flucelvax (TIV) for Influenza prophylaxis, dose: not reported, route of administration: not reported, anatomical location: not reported, Lot number: 946615. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date, the patient experienced Ingredients of vaccine following possible allergic reaction (outcome: Not Reported). Consumer called to inquire about ingredients of vaccine following possible allergic reaction after her daughter was given the vaccine in October, specific type of reaction not provided. Covid vaccine was also mentioned as a suspected source of allergy, although product information was not specified. Caller refused to provide patient information. Flucelvax (TIV) action taken: Not Applicable Reporter's assessment: The reporter considered the events Ingredients of vaccine following possible allergic reaction related to the administration of Flucelvax (TIV) and seriousness was not provided.; Reporter's Comments: Event is related
Comments: None